The success of treating psoriasis with GLP-1 agonists has been documented in case reports and a prospective cohort study performed in 2019
A study published in 2009 issue of Gastroenterology scientific journal reported only one in 100,000 people have gastroparesis (Jung HK, Choung RS, Locke GR III, et al
Karger Publishers.
Initialement dvelopps pour rguler la glycmie, ces traitements appels agonistes du GLP-1 imitent une hormone naturelle, le Glucagon-Like Peptide-1 , qui joue un rle majeur dans la satit , la gestion de lapptit et la stabilisation du sucre sanguin
Fatigue may arise indirectly through gastrointestinal disturbances, reduced caloric intake, or blood glucose fluctuations
Good care means identifying the signals source and tracking whether the treatment is actually changing the underlying biology